Pfizer Secures $10 Billion Weight-Loss Startup Metsera, Intensifying GLP-1 Race
Pfizer wins a $10 billion bidding war for weight-loss startup Metsera, securing a pipeline of next-generation oral GLP-1 agonists. Analysis of the strategic move and market impact.